BRIEF-Core Laboratories Expects Q126 Revenue And Earnings Below Prior Guidance

Reuters03-24
BRIEF-Core Laboratories Expects Q126 Revenue And Earnings Below Prior Guidance

March 23 (Reuters) - Core Laboratories Inc CLB.N:

  • CORE LABORATORIES OUTLOOK Q1 EPS USD 0.05-0.07

  • CORE LABORATORIES INC - PROJECTS Q1 2026 EPS, EX-ITEMS, OF $0.05-$0.07

  • CORE LABORATORIES INC - RESERVOIR DESCRIPTION SEGMENT MORE IMPACTED BY MIDDLE EAST CONFLICT

  • CORE LABORATORIES INC - PRODUCTION ENHANCEMENT LESS AFFECTED; ENERGETICS SHIPMENTS DELAYED OR SUSPENDED

  • CORE LABORATORIES INC: REVISED GUIDANCE FOR Q1 2026 REVENUE RANGES FROM $119 MILLION TO $123 MILLION

  • CORE LABORATORIES INC - EXPECTS Q1 2026 REVENUE AND EARNINGS BELOW PRIOR GUIDANCE

  • CORE LABORATORIES OUTLOOK Q1 ADJUSTED EPS USD 0.05-0.07

Source text: [ID:]

Further company coverage: CLB.N

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment